Valeant names Howard Schiller as interim CEO


Valeant Pharmaceuticals has named former finance chief Howard Schiller as interim CEO while the troubled drug company's chairman and chief executive remains hospitalized with severe pneumonia. Valeant said Tuesday that J. Michael Pearson is still on medical leave, and it did not know when he would return.



from Biotech News